ZenaTech, holding nearly 20% of Boardwalktech shares, has formally requested regulatory intervention after Boardwalktech scheduled a special meeting in January 2027 but failed to call its mandatory 2026 annual general meeting (AGM). ZenaTech accuses Boardwalktech's board of poor governance, lack of independence, and non-compliance with securities laws, including improper management salaries amid financial struggles. ZenaTech seeks to replace the current board, restore proper governance, and ensure shareholder rights by compelling an immediate AGM and halting extraordinary transactions until compliance is met. This conflict highlights significant governance and financial issues at Boardwalktech, with potential regulatory and legal actions pending.
Regarding the open letter from ZenaTech to Boardwalktech shareholders about governance issues, here is Pluang's Technology sector market snapshot as of Oct 21, 2026 03:11 WIB: Of 150 priced US Technology stocks, 108 rose and 40 fell today. Notable movers include SMCI at USD 36.27 with a +12.99% change and 87% buy order activity, BB at USD 8.85 up +8.46% but with 99% sell orders, and MNDY at USD 100.64 rising +7.73% with 100% sell orders. The most notable figure is SMCI's +12.99% daily gain.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
